HIT IQ was founded to advance athlete safety and performance, developing the Nexus A9 iMG and starting global data collection on head impacts and concussion assessments.

iMGs were introduced to the National Rugby League (NRL), with over 500 iMGs deployed to understand the impact and severity of head impacts.

900 Nexus A9 iMGs were deployed across AFL teams, scaling data collection by monitoring athletes and capturing head impacts.

HIT IQ secured its position as the standard for impact monitoring in Australian football through a league-wide agreement with the AFL, deploying 3,000 Nexus A9 iMGs across all 18 teams, including elite, community, junior, and AFLW levels. Over 2,000 additional iMGs have been deployed globally in the past two years. Patents were secured, research partnerships established, and third-party risk models developed using HIT IQ’s growing dataset.

Partnerships with the Canterbury Crusaders and Rugby Australia were strengthened, and 12 NCAA D1 Football Programs in North America captured 70,000 head impacts, growing the global databank.

Over 4,000 iMGs were deployed worldwide, backed by robust IP, contributing to the largest global database over 7 years and establishing HIT IQ's leadership in athlete safety, risk models, and policy influence.

The Nexus A9 iMG was first deployed in the Australian Football League (AFL) with select teams contributing to early data collection.

Nexus A9 iMGs were deployed in North America, the UK, and Japan, with key partners including UFC, Bath Rugby, and various universities, introducing personalized player data tracking.

iMGs were deployed in the AFL Women’s league and extended to community and junior sports, with cognitive assessments surpassing 130,000, informing OH&S policy.

Collaboration with Shock Doctor, Inc., aimed at developing an over-the-counter instrumented mouthguard, targeted the grassroots market, demonstrating technology fit for elite and consumer markets.